Alector (ALEC) Liabilities and Shareholders Equity (2018 - 2026)

Alector (ALEC) reported Liabilities and Shareholders Equity of $239.9 million for Q1 2026, down 41.24% year-over-year from $408.3 million in Q1 2025, and down 18.18% quarter-over-quarter from $293.2 million in Q4 2025.

Alector (ALEC) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends

Alector (ALEC) has 9 years of Liabilities and Shareholders Equity data on file, last reported at $239.9 million in Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $239.9 million, down 41.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (down 37.61% YoY), and the FY2025 annual result was $293.2 million, down 37.38% from the prior year.
  • Liabilities and Shareholders Equity slipped to $239.9 million in Q1 2026 per ALEC's latest filing, from $293.2 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $954.5 million in Q1 2022 and troughed at $239.9 million in Q1 2026.
  • A 5-year average of $590.8 million and a median of $621.8 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2022 and 2026: Liabilities and Shareholders Equity soared 124.03% in 2022, then plunged 41.24% in 2026.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $787.6 million in 2022, then declined by 21.05% to $621.8 million in 2023, then decreased by 24.69% to $468.3 million in 2024, then sank by 37.38% to $293.2 million in 2025, then decreased by 18.18% to $239.9 million in 2026.
  • Business Quant data shows ALEC's Liabilities and Shareholders Equity at $239.9 million in Q1 2026, $293.2 million in Q4 2025, and $335.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.37 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 14.93 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.73 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 23.64 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 33.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.48 Bn
9 Abivax 91.96 Bn 91.96 Bn - 640.56 Mn
10 Alector 193.53 Mn -12.98 Mn - 239.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 239.92 Mn
Dec 31, 2025 293.24 Mn
Sep 30, 2025 335.29 Mn
Jun 30, 2025 356.42 Mn
Mar 31, 2025 408.30 Mn
Dec 31, 2024 468.30 Mn
Sep 30, 2024 516.02 Mn
Jun 30, 2024 570.73 Mn
Mar 31, 2024 635.49 Mn
Dec 31, 2023 621.83 Mn
Sep 30, 2023 672.40 Mn
Jun 30, 2023 708.74 Mn
Mar 31, 2023 748.34 Mn
Dec 31, 2022 787.65 Mn
Sep 30, 2022 837.04 Mn
Jun 30, 2022 889.67 Mn
Mar 31, 2022 954.46 Mn
Dec 31, 2021 814.66 Mn
Sep 30, 2021 854.23 Mn
Jun 30, 2021 397.11 Mn